Skip to NavigationSkip to content

Scheuble quits as Merck KGaA chief

Published on 05/12/05 at 11:45am

Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought to be behind the resignation.

The company is controlled by the Merck family council, and Scheuble's frustration with Merck's failure to build a strong presence in the US is said to be a cause of friction.

Dr Michael Roemer has been named as the new chief executive and chairman of the company, having been promoted from his previous role as head of production, engineering, purchasing and other key business functions.

Elmar Schnee has been appointed as head of the company's pharmaceutical division, expanding his existing role which currently covers prescription medicines only.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches